Insulin receptor antibodies inhibit insulin uptake by the liver: In vivo 123i-insulin scintigraphic scanning and in vitro characterization in autoimmune hypoglycemia

Journal of Investigative Medicine

Volumn 49, Issue 1, 2001, Pages 85-92

  Dozio, N ^a   Sarugeri, E ^a   Scavini, M ^a   Beretta, A ^a   Belloni, C ^a   Dosio, F ^a   Savi, A ^a   Fazio, F ^a   Sodoyez Goffaux, F ^a   Pozza, G ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Autoimmunity; Diagnostic imaging; Hypoglycemia; Insulin receptor antibodies; Insulin resistance

Indexed keywords

IMMUNOGLOBULIN SUBCLASS; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR ANTIBODY; IODINE 123;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; BETA CHAIN; CASE REPORT; CONTROLLED STUDY; HORMONE TRANSPORT; HUMAN; HYPOGLYCEMIA; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; INSULIN DEGRADATION; INSULIN LIKE ACTIVITY; LIVER; MALE; PHOSPHORYLATION; SCINTIGRAPHY;

EID: 0035146674     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains
2. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
3. 123I-Insulin metabolism in normal rats and humans: External detection by a scintillation camera
4. 123I-insulin metabolism in rats
5. 123I-insulin. In vivo studies in rats
6. Effects of insulin antibodies on bioavailability of insulin: Preliminary studies using 123-I-insulin in patients with insulin-dependent diabetes
7. Imaging of the buffering effect of insulin antibodies in the autoimmune hypoglycaemic syndrome
8. 123I]insulin scanning
9. 123I-labeled insulin and scintigraphic scanning in severe insulin resistance
10. Differential signalling potential of insulin and IGF-1 receptor cytoplasmic domains
11. Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors
12. Heterogenous IgG subclass distribution of islet cell antibodies
13. Investigation of the mechanism of the dominant negative effect mutations in the Tyrosine kinase domain of the insulin receptor
14. Insulin radioreceptor assay for human and erythrocytes
15. Membrane receptors as autoantigens: Myasthenia gravis as a prototype of a new family of diseases
16. The syndrome of insulin resistance and acanthosis nigricans (Insulin-receptor disorders in man)
17. Characterization of antibodies to the insulin receptor. A cause of insulin-resistant diabetes in man
18. Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action
19. Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor
20. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance
21. Insulin receptor antibody found in a case of Sjogren Syndrome associated with extreme insulin resistant diabetes
22. Atypical anti-insulin receptor antibodies in a patient with type B insulin resistance and scleroderma
23. Anti-insulin receptor antibodies and diabetes
24. Insulin resistant diabetes with insulin receptor autoantibodies in a male with acanthosis nigricans
25. Modulation of binding and bioactivity of insulin by anti-insulin antibody: Relation to possible role of receptor self-aggregation in hormone action
26. Characterization of insulin-like actions of anti-insulin receptor antibodies. Effects on insulin binding, insulin degradation and glycogen synthesis in isolated rat hepatocytes
27. Effects of anti-insulin receptor autoantibodies on the metabolism of human adipocytes
28. Anti-insulin receptor autoantibodies inhibit binding and stimulate glucose metabolism in skeletal muscle
29. Effects of autoantibodies to the insulin receptor on isolated adipocytes
30. The role of anti-receptor antibodies in stimulating phosphorylation of the insulin receptor
31. Anti-receptor antibodies mimic the effect of insulin to downregulate insulin receptors in cultured human lymphoblastoid (IM9) cells
32. Antibody against the insulin receptor causes disappearance of insulin receptor in 3T3-L1 cells: A possible explanation of antibody-induced insulin resistance
33. Desensitization of the insulin receptor at an early postreceptor step by prolonged exposure to anti-receptor antibody
34. In vivo and in vitro effects of anti-insulin receptor antibodies
35. Characterization of the serum from a patient with insulin resistance and hypoglycemia. Evidence for multiple populations of insulin receptor antibodies with different receptor binding and insulin-mimicking activities
36. Demonstration of heterogeneity of autoantibodies to insulin receptors in type B insulin resistance by isoelectric focusing
37. Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes of the human insulin receptor
38. 125-I-insulin. Kinetics of interaction with its receptors and rate of degradation in vivo
39. Substitution of leu for Pro-193 in the insulin receptor in a patient with a genetic form of severe insulin resistance
40. Evidence that two naturally occurring human insulin receptor a-subunit variants are immunologically distinct
41. Insulin receptor signaling in the beta-cell influences insulin gene expression and insulin content: Evidence for autocrine beta-cell regulation
42. Insulin stimulated insulin secretion in single pancreatic beta cells
43. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes